Developing a liquid chromatography-tandem mass spectrometry (LC-MS/MS) method for the simultaneous determination of phosphodiesterase-5 inhibitors in health supplements in Vietnam
MedPharmRes · 31.03.2026 · 10 (1) · 62-75
DOI: 10.32895/mpr.25.00074 ↗Kurz gefasst
Fachartikel in der Zeitschrift MedPharmRes, online erschienen am 31.03.2026. Verfasst von Tram Thi Nguyen und 6 weiteren Autor:innen. Die Arbeit nennt 16 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Sildenafil, tadalafil, vardenafil, sulfoaildenafil, amino tadalafil, N-desmethyl tadalafil are phosphodiesterase type-5 (PDE-5) inhibitors that have been frequently detected as adulterants in sexual enhancement supplements. They are prohibited under Circular No.10/2021/TT-BYT of the Ministry of Health of VietNam, dated June 30, 2021. This study aimed to develop and to apply a liquid chromatography-tandem mass spectrometry (LC-MS/MS) procedure to simultaneously determine these substances in health supplements. The study was performed using a simulated sample containing analytes, herbals and excipients. Chromatographic and MS parameters were optimized through investigation. The analytical method was developed using LC-MS/MS with electrospray ionization positive (ESI+) mode and validated in accordance with Association of Official Analytical Chemists (AOAC) regulations. The established method was then applied to determine the presence of adulterated PDE-5 inhibitors in health protection products obtained from the Vietnamese market. The developed analytical procedure featured the following settings: the column was InertSustain C18 (2.1×150 mm, 3 μm); mobile phase consists of 0.1% formic acid in water and 0.1% formic acid in acetonitrile; flow rate was maintained at 0.20 mL/min and analytes were eluted via a solvent gradient program. The analytical procedure met the requirements of AOAC. Analysis results from the health supplement samples revealed that 25% of the total samples collected were found to be adulterated with PDE-5 inhibitors (6 out of 24 collected samples). A LC-MS/MS procedure for simultaneously determining sildenafil, tadalafil, vardenafil, sulfoaildenafil, amino tadalafil, N-desmethyl tadalafil in health supplements was developed, validated, and applied.
Zitieren
APA
Nguyen, T. T., Pham, S. V., Chuong, N. N., Le, T. V., Le, T. T., Truong, H. T., & Phan, D. T. (2026). Developing a liquid chromatography-tandem mass spectrometry (LC-MS/MS) method for the simultaneous determination of phosphodiesterase-5 inhibitors in health supplements in Vietnam. MedPharmRes, 10(1), 62-75. https://doi.org/10.32895/mpr.25.00074
Vancouver
Nguyen TT, Pham SV, Chuong NN, Le TV, Le TT, Truong HT, et al. Developing a liquid chromatography-tandem mass spectrometry (LC-MS/MS) method for the simultaneous determination of phosphodiesterase-5 inhibitors in health supplements in Vietnam. MedPharmRes. 2026;10(1):62-75. doi:10.32895/mpr.25.00074
BibTeX
@article{Nguyen2026,
author = {Nguyen, Tram Thi and Pham, Son Van and Chuong, Nai Ngoc and Le, Tran Van-Hoai and Le, Thuong Thi-Thuong and Truong, Hien Thuy and Phan, Dung Thanh},
title = {Developing a liquid chromatography-tandem mass spectrometry (LC-MS/MS) method for the simultaneous determination of phosphodiesterase-5 inhibitors in health supplements in Vietnam},
journal = {MedPharmRes},
year = {2026},
volume = {10},
number = {1},
pages = {62--75},
doi = {10.32895/mpr.25.00074}
}
EUVIMED